HomeAbout usHospitalsSearchLogin
Your medical data, safe and secure.
Name
BILN 2061
Description
The compound, named BILN 2061, is an orally active inhibitor of the HCV NS3 protease and the first member of this new drug class to be tested in humans.
No brand information found.
